Find a Clinical Trial | Pfizer Clinical Trials

23 trials found for Lung Neoplasm, Lung Carcinoma, Lung cancer

Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma, Pediatric Oncology, Pediatric Lung cancer, Pediatric Lung Neoplasm, Pediatric Lung Carcinoma

A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01).

Carcinoma, Non-Small-Cell Lung

Safety and Efficacy of Lorbrena

Non-small Cell Lung Cancer, Pediatric Oncology, Pediatric Lung cancer, Pediatric Lung Neoplasm, Pediatric Lung Carcinoma

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer, Malignant Neoplasms, Brain Neoplasms, Colorectal Cancer, Pediatric Oncology, Pediatric Lung cancer, Pediatric Lung Neoplasm, Pediatric Lung Carcinoma

Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene

Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma

A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma

Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

ALK+ Non-Small-Cell Lung Carcinoma

Male or Female

18+ years

1study location(s)